Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Monoclonal MEF2A Primary Antibody for ELISA, WB - ABIN1724919
Guella, Rimoldi, Asselta, Ardissino, Francolini, Martinelli, Girelli, Peyvandi, Tubaro, Merlini, Mannucci, Duga: Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease. in Circulation. Cardiovascular genetics 2009
Show all 2 Pubmed References
Human Polyclonal MEF2A Primary Antibody for IHC - ABIN966556
Kato, Zhao, Morikawa, Sugiyama, Chakravortty, Koide, Yoshida, Tapping, Yang, Yokochi, Lee: Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. in The Journal of biological chemistry 2000
Show all 2 Pubmed References
Human Polyclonal MEF2A Primary Antibody for IHC - ABIN966555
Zhao, New, Kravchenko, Kato, Gram, di Padova, Olson, Ulevitch, Han: Regulation of the MEF2 family of transcription factors by p38. in Molecular and cellular biology 1999
Show all 2 Pubmed References
Human Polyclonal MEF2A Primary Antibody for IF, IHC - ABIN361950
Satoh, Ohnishi, Sato, Takeyama, Iemura, Natsume, Shibuya: Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development. in Molecular and cellular biology 2007
Human Polyclonal MEF2A Primary Antibody for IHC, IHC (p) - ABIN4333438
Zehorai, Seger: Beta-like importins mediate the nuclear translocation of mitogen-activated protein kinases. in Molecular and cellular biology 2013
in leiomyosarcomas (LMS), this two-faced trait of MEF2 is relevant for tumor aggressiveness. Class IIa HDACs are overexpressed in 22% of LMS, where high levels of MEF2, HDAC4 (show HDAC4 Antibodies) and HDAC9 (show HDAC9 Antibodies) inversely correlate with overall survival. The knock out of HDAC9 (show HDAC9 Antibodies) suppresses the transformed phenotype of LMS cells, by restoring the transcriptional proficiency of some MEF2-target loci
The discovery of a novel MEF2A mutation in a Chinese family with premature CAD (show CAD Antibodies)/MI suggests that MEF2A may have a significant role in the pathogenesis of premature CAD (show CAD Antibodies)/MI.
The findings of this study are consistent with MEF2A deregulation conferring risk of formal thought disorder.
Variants in the 3'-UTR of MEF2A are associated with coronary artery disease in a Chinese Han population.
p38 MAPK (show MAPK14 Antibodies) is a key regulator of canonical Wnt (show WNT2 Antibodies) signaling by promoting a phospho-dependent interaction between MEF2 and beta-catenin (show CTNNB1 Antibodies) to enhance cooperative transcriptional activity and cell proliferation.
Mechanistically, MEF-2 (show MYEF2 Antibodies) was recruited to the viral promoter (LTR, long terminal repeat) in the context of chromatin, and constituted Tax (show CNTN2 Antibodies)/CREB (show CREB1 Antibodies) transcriptional complex via direct binding to the HTLV-1 LTR.
Our results revealed a link and interaction between MEF2A and miR (show MLXIP Antibodies)-143 and suggested a potential mechanism for MEF2A to regulate H(2)O(2) -induced VSMC senescence.
six or seven amino acid deletions and synonymous mutations (147143G-->A)in exon 11 of the MEF2A gene may be correlated with susceptibility to coronary artery disease in the Chinese population
MEF2A is targeted to lysosomes for chaperone-mediated autophagy degradation; oxidative stress-induced (show SQSTM1 Antibodies) lysosome destabilization leads to the disruption of MEF2A degradation as well as the dysregulation of its function
MEF2 transcription factors promotes epithelial-mesenchymal transition and invasiveness of hepatocellular carcinoma through TGF-beta1 (show TGFB1 Antibodies) autoregulation circuitry.
Deficiency of AKT2 (show AKT2 Antibodies) in myocardium results in diminished MEF2A abundance, which induced decreased size of cardiomyocytes. We additionally confirmed that EndoG (show ENDOG Antibodies), which is also regulated by AKT2 (show AKT2 Antibodies), is a suppressor of MEF2A in myocardium.
these data indicate that MEF2 (show MEF2C Antibodies) and AP-1 (show JUN Antibodies) confer antagonistic regulation of Hspb7 (show HSPB7 Antibodies) gene expression in skeletal muscle, with implications for autophagy and muscle atrophy.
Nuclear HDAC4 (show HDAC5 Antibodies) binds to chromatin as well as to MEF2A transcription factor, leading to histone deacetylation and altered neuronal gene expression. By using a Cdkl5 (show CDKL5 Antibodies) knockout (Cdkl5 (show CDKL5 Antibodies) -/Y) mouse model, we found that hypophosphorylated HDAC4 (show HDAC5 Antibodies) translocates to the nucleus of neural precursor cells, thereby reducing histone 3 acetylation.
Knockdown of MEF2A significantly reduced hyperglycemia-induced cardiac fibroblast proliferation and migration, myofibroblast differentiation, matrix metalloproteinase activities, and collagen production.
Lentivirus-mediated MEF 2A shRNA accelerates inflammation and atherosclerosis in APOE (show APOE Antibodies) knockout mice, but has no effect on lipoprotein levels in plasma.
microRNAs encoded by the Gtl2-Dio3 (show DIO3 Antibodies) noncoding RNA locus function downstream of the MEF2A
Our results indicated that exercise-induced CPT1b (show CPT1B Antibodies) expression was at least in part mediated by HDAC5 (show HDAC5 Antibodies)/MEF2A interaction.
Whereas MEF2A is absolutely required for proper myoblast differentiation, MEF2B (show MEF2B Antibodies), -C, and -D were found to be dispensable for this process.
A role for endogenous MEF2 (show MEF2C Antibodies) factors exclusively in hormone/Fsk/cAMP-induced Nr4a1 (show NR4A1 Antibodies) gene expression in mouse MA-10 Leydig cells.
Mef2 (show MYEF2 Antibodies) controls skeletal muscle formation after terminal differentiation.
Results suggest that myocyte-specific enhancer factor 2A is essential for cardiac contractility
Results suggest that myocyte enhancer factor 2A is essential for zebrafish posterior somite development.
polymorphisms in the bovine MEF2A gene and their effect on the MEF2A mRNA expression level in the longissimus dorsi muscle
These results show that NLK specifically regulates the MEF2A activity required for anterior formation in Xenopus development.
The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.
MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)
, myocyte-specific enhancer factor 2A
, serum response factor-like protein 1
, myocyte enhancer factor 2a
, myocyte-specific enhancer factor 2a
, myocyte-specific enhancer factor 2A homolog
, serum response factor-like protein 2
, myocyte enhancer factor 2A
, myocyte-specific enhancer factor 2A-like